These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 33048118

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
    Perkins RB, Lin M, Wallington SF, Hanchate A.
    Sex Transm Dis; 2017 Jun; 44(6):365-370. PubMed ID: 28499288
    [Abstract] [Full Text] [Related]

  • 23. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V, Fett S, Tauscher M, Donnachie E, Schneider A, Klug SJ.
    BMC Cancer; 2022 Dec 09; 22(1):1293. PubMed ID: 36494790
    [Abstract] [Full Text] [Related]

  • 24. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
    Mariani L, Vici P, Suligoi B, Checcucci-Lisi G, Drury R.
    Adv Ther; 2015 Jan 09; 32(1):10-30. PubMed ID: 25620536
    [Abstract] [Full Text] [Related]

  • 25. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S, Mizrachi Y, Chodick G, Katz R, Schejter E.
    Gynecol Oncol; 2017 Aug 09; 146(2):299-304. PubMed ID: 28602548
    [Abstract] [Full Text] [Related]

  • 26. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A, Iftner T, Iftner A, Riedle S, Ocak M, Luyten A, Üye I, Tunc K, Petry KU.
    BMC Infect Dis; 2021 Jul 02; 21(1):634. PubMed ID: 34215215
    [Abstract] [Full Text] [Related]

  • 27. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J, Perkins N.
    N Z Med J; 2011 Jul 29; 124(1339):51-8. PubMed ID: 21952330
    [Abstract] [Full Text] [Related]

  • 28. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.
    Sonnenberg P, Tanton C, Mesher D, King E, Beddows S, Field N, Mercer CH, Soldan K, Johnson AM.
    Sex Transm Infect; 2019 Aug 29; 95(5):386-390. PubMed ID: 30723185
    [Abstract] [Full Text] [Related]

  • 29. Real world effectiveness of population-based roll out of human papillomavirus vaccination against rates of genital warts.
    Smith JS, Weiderpass E.
    J Natl Cancer Inst; 2013 Apr 03; 105(7):449-51. PubMed ID: 23486549
    [No Abstract] [Full Text] [Related]

  • 30. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
    Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.
    BMC Cancer; 2013 Jan 08; 13():10. PubMed ID: 23298365
    [Abstract] [Full Text] [Related]

  • 31. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.
    BMC Infect Dis; 2013 Feb 07; 13():75. PubMed ID: 23390964
    [Abstract] [Full Text] [Related]

  • 32. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
    Bossart S, Gabutti MP, Seyed Jafari SM, Hunger RE.
    Dermatol Ther; 2020 Jul 07; 33(4):e13771. PubMed ID: 32500585
    [Abstract] [Full Text] [Related]

  • 33. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB, Legler A, Hanchate A.
    Sex Transm Dis; 2015 Dec 07; 42(12):665-8. PubMed ID: 26562694
    [Abstract] [Full Text] [Related]

  • 34. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM.
    BMC Med; 2013 Oct 22; 11():227. PubMed ID: 24148310
    [Abstract] [Full Text] [Related]

  • 35. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P, Tobe K, Abe M, Elbasha EH.
    BMC Infect Dis; 2021 Jan 06; 21(1):11. PubMed ID: 33407188
    [Abstract] [Full Text] [Related]

  • 36. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL, Joura EA.
    BioDrugs; 2011 Oct 01; 25(5):339-43. PubMed ID: 21942919
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
    Ali H, McManus H, O'Connor CC, Callander D, Kong M, Graham S, Saulo D, Fairley CK, Regan DG, Grulich A, Low N, Guy RJ, Donovan B.
    Med J Aust; 2017 Mar 20; 206(5):204-209. PubMed ID: 28301790
    [Abstract] [Full Text] [Related]

  • 38. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM, Heywood A, Heley S.
    Sex Health; 2009 Sep 20; 6(3):178-84. PubMed ID: 19653953
    [Abstract] [Full Text] [Related]

  • 39. Increased incidence of genital warts among women and men with type 1 diabetes compared with the general population-results from a nationwide registry-based, cohort study.
    Reinholdt K, Munk C, Thomsen LT, Dehlendorff C, Carstensen B, Jørgensen ME, Kjaer SK.
    Acta Diabetol; 2022 Jan 20; 59(1):105-112. PubMed ID: 34499240
    [Abstract] [Full Text] [Related]

  • 40. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ.
    BMJ; 2013 Apr 18; 346():f2032. PubMed ID: 23599298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.